Navigation Links
Synteract Sponsoring and Presenting at Outsourcing in Clinical Trials Southeast Conference
Date:5/8/2012

SAN DIEGO and RALEIGH-DURHAM, N.C., May 8, 2012 /PRNewswire/ -- Synteract, Inc., a full-service contract research organization (CRO), will be a corporate sponsor and have two senior level directors from its Research Triangle Park office speak at the inaugural Outsourcing in Clinical Trials Southeast conference to be held at the Durham Marriott Convention Center, May 15-16, 2012. Barbara Conley, associate director of clinical operations, and Matt Anders, associate director of project management, will co-present at 10:30 a.m. EDT, Wed., May 16th, on how to identify viable investigative sites that contribute to the success of a company's clinical study.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO

The conference series is nationally respected and attended by vendors and sponsors in the pharmaceutical and biotech industries. Conley and Ander's presentation will address one of the growing concerns within drug development; how to find and choose viable trial sites.

Topics will include: 

  • Identifying what makes a site feasible for your trial
  • Establishing whether a site has ongoing studies competing for the same patient population
  • Assessing whether the site meets the country's standard of care  
  • Forecasting whether the length of your trial is acceptable to investigational staff and patients
  • Evaluating the availability of specialized equipment and expertise
  • Analyzing the consistency of the investigator budget with the level of investigational site effort required

According to Synteract executives, with trial costs on the rise finding appropriate investigative sites is a key driver in efficient trial conduct.  With site selection a critical component in the overall drug development process, it is important for biopharma companies of all sizes to work with a CRO that can facilitate choosing viable trial sites.

"After nearly two decades of operations, we're known for having a unique understanding of emerging pharma and biotech, particularly on the West Coast, where we are headquartered," stated Stewart Bieler, chief operating officer. "We continue to enhance the breadth and depth of our Raleigh-based service offering in response to increasing East Coast-based client demand.  This allows us to continue to offer a level of individualized service from experienced clinical development professionals on each project."

Synteract will exhibit at booth #27. CEO Wendel Barr will be available to discuss the company's Shared Work-Shared Vision approach where every project and client receives collaborative, customized service that is tailored to their needs. To set up an appointment in advance, contact Michele Sacher, associate business development director, at 484.467.5937 or msacher@synteract.com

About Synteract (www.synteract.com)
Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.  With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology. 

CONTACT:
Rachel Hutman
Clearpoint Agency, for Synteract
rachel@clearpointagency.com
+1-760-230-2424


'/>"/>
SOURCE Synteract, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure
2. Synteract Expands Executive Roles to Support Growth
3. Synteract Hosting CDISC Classes on Regulatory Data Standards, Feb. 21-24, in California
4. Former Synteract CEO Unveils Non-Profit Contract Research Organization, PHACT, to Help Eliminate Neglected Diseases in Developing Countries
5. Synteract Releases SynCapture Version 1.5 of Its Hybrid Electronic Data Capture (EDC) System
6. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
7. Attorney Mark Lanier Presenting Keynote at National Mesh Litigation Conference
8. Parata Systems Announces Presenting Sponsorship of 2012 Independent Pharmacy Business Growth Conference
9. Genprex Presenting at 10th Annual BIO Investor Forum
10. AMD Alliance, Representing AMD Patient Organizations Globally, Encourages Health Care Providers to Stop Using Avastin for Off-Label Ocular Use
11. Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... 12, 2017 , ... On Saturday, October 21, the Health & Wellness Center ... to raise money for the American Heart Association Heart Walk. Teams of up to ... together to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 ...
Breaking Medicine News(10 mins):